Board of Advisors
Our Board of Advisors, all industry leaders, have made a powerful statement by supporting Life Science Cares and our goal to end poverty in our community. Our Advisors make a personal financial contribution annually to make our mission and model possible.
Our Board of Advisor members also choose to volunteer with their companies and recruit their colleagues to join in this collective effort.
NEW YORK BOARD OF ADVISORS
ABCDEFGHIJKLMNOPQRSTUVWXYZ
Michael Aberman
Founder and CEO – Xenimmune Therapeutics, Inc.
Sandip Agarwala
Managing Director – Blue Owl Capital
Jennifer Bland
CEO – New York Bio
Laurence Blumberg
Biotechnology Executive
Laurence Blumberg
Biotechnology Executive
Geoff Brzuchalski
Partner – PwC
Alexandra Cantley
Partner – Polaris Partners
Kyle Carver
Chief Financial Officer – Evommune
Cara Cassino
President – Stony Point Life Sciences Consulting LLC
Kerry Clem
CCO – Acorda Therapeutics
Bryan Czyzewski
Managing Director – Jefferies
Holly Fleiss
Managing Director – JP Morgan
Zandy Forbes
CEO – MeiraGTx
Martin Friedman
Managing Member – Pharmakon Advisors
Anjali Ganguli
Chief Business Officer – Syndax Pharmaceuticals
Matthew Gline
CEO – Roivant Sciences
Div Gupta
Partner – Cooley LLP
Bill Harvey
Executive Vice President – JLL
Laurent Hermouet
Partner – Athyrium
Ruby Holder
CSO – Proteovant Therapeutics
Kristian Humer
Chief Financial & Business Officer – Viridian Therapeutics
Darren Jones
Partner – Baker Tilly
Bj Jones
Chief Commercial Officer – Biohaven
Patrick Jordan
Chairman – World Orphan Drug Alliance (WODA)
Michael Karmiol
Head of Healthcare Equity Capital Markets – BTIG
Cristina Larkin
CEO – CLC Insights LLC
Matthew Leskowitz
Managing Director – Goldman Sachs
Michael Margolis
Senior Managing Director – Oppenheimer & Co. Inc.
Evan Markou
Senior Client Partner – Korn Ferry
Scott Metzner
Founder & Principal – Janus Property
Matthew Moore
Chief Business Officer – Arcutis Biotherapeutics, Inc.
Scott Morenstein
Managing Director – Blackstone Alternative Asset Management
Frank Nestola
Founding Partner – Coefficient Health
Edwin O'Connor
Partner – Goodwin
Eric Poma
CEO & CSO – Molecular Templates (MTEM)
Andrea Rabney
President and CEO – Argot Partners
Nishta Rao
Managing Director – First Republic Bank
Alan S. Roemer
Board Chair & Member – Various Biotechnology Companies
Jeff Rowbottom
Partner – Iron Park Capital
Paul J Sekhri
President & CEO – vTv Therapeutics LLC
Jesse Shefferman
CEO – Protara Therapeutics, Inc.
Brian Skorney
Managing Director – Baird
Lilian Stern
Principal – Stern Investor Relations
Arthur Stril
Chief Business Officer – Cellectis
Dan Swisher
President & Chief Operating Officer – Jazz Pharmaceuticals
Richard Truesdell
Partner – David Polk & Wardwell LLP
Ben van der Schaaf
Partner – Arthur D. Little